Pharmacokinetics, safety, and efficacy of trastuzumab deruxtecan with concomitant ritonavir or itraconazole in patients with HER2-expressing advanced solid tumors

Takahashi S.Karayama M.Takahashi M.Watanabe J.Minami H.Yamamoto N.Kinoshita I.CHIA-CHI LINIm Y.-H.Achiwa I.Kamiyama E.Okuda Y.Lee C.Bang Y.-J.2022-09-152022-09-1520211078-0432https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119055457&doi=10.1158%2f1078-0432.CCR-21-1560&partnerID=40&md5=9763e8993a09a3da8f8f7d4378489a60https://scholars.lib.ntu.edu.tw/handle/123456789/620210Pharmacokinetics, safety, and efficacy of trastuzumab deruxtecan with concomitant ritonavir or itraconazole in patients with HER2-expressing advanced solid tumorsjournal article10.1158/1078-0432.CCR-21-1560344264422-s2.0-85119055457